AIA
AVNS

Allegis Investment Advisors’s Avanos Medical AVNS Stock Holding History

Allegis Investment Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-254
Closed -$8K – 239
2015
Q4 		$8K Buy
+254
New +$7.9K ﹤0.01% 719

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CI
Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return

Allegis Investment Advisors's AVNS Position: Q1 2016 in Review

Allegis Investment Advisors sold out of Avanos Medical (AVNS) in Q1 2016, closing a stake of 254 shares — an estimated $8K sold.

Allegis Investment Advisors first reported a position in AVNS in Q4 2015 and held it in 1 quarter. The position peaked at $8K in Q4 2015. 333 funds tracked by Wall St. Rank hold AVNS as of Q1 2016.

  • Allegis Investment Advisors reported no remaining Avanos Medical position as of Q1 2016 after selling out during the quarter.
  • Allegis Investment Advisors sold 254 Avanos Medical shares in Q1 2016, an estimated $8K.
  • Allegis Investment Advisors first reported a position in Avanos Medical in Q4 2015 and held it in 1 quarter.
  • Allegis Investment Advisors's Avanos Medical position peaked at $8K in Q4 2015.
  • 333 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2016.

Based on Allegis Investment Advisors's 13F filing for Q1 2016, filed 9 May 2016.